v3.24.4
SCHEDULE OF OTHER INCOME, GAINS OR LOSSES (Details) (Parenthetical) - USD ($)
 6 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Notes and other explanatory information [abstract]        
Preferred shares $ 3,539,648 [1] $ 5,044,000 [1] $ 4,101,000 [2] $ (1,841,000) [2]
Convertible loan percentage 8.00%   8.00% 8.00%
Convertible loan $ 4,350,000 3,350,000 $ 3,350,000 $ 3,250,000
Loss on fair value of convertible notes $ 274,000 [3] $ 126,000 [3] $ 374,000 [4] 19,000 [4]
Preferred shares, loss       $ 1,841,000
[1] The preferred shares were fair valued, using an equity allocation model at the end of each reporting period, which resulted in a gain of $3,539,648 for the period ended 30 September 2024 (30 September 2023: a gain of $5,044,000).
[2] The preferred shares were fair valued, using an equity allocation model at the end of each reporting period, which resulted in a gain of $4,101,000 for the year ended 31 March 2024 (2023: loss of $1,841,000).
[3] The Group has issued 8% convertible loan notes. At 30 September 2024, there were $4,350,000 notes outstanding (30 September 2023: $3,350,000). The notes were fair valued at the end of each reporting period, resulting in a loss of $274,000 during the period ended 30 September 2024 (30 September 2023: loss of $126,000).
[4] During the year ended 31 March 2024 and 2023, the Group issued 8% convertible loan notes. At 31 March 2024, there were outstanding notes with aggregate face values of $3,350,000 (2023: $3,250,000). The notes were fair valued at the end of each reporting period, resulting in a loss of $374,000 for the year ended 31 March 2024 (2023: loss of $19,000).